Kelly Price

Kelly Price has over 16 years of work experience in various roles within the pharmaceutical and healthcare industry. Kelly is currently serving as the US Head of Rare Disease at HRA Pharma. Prior to this, they worked as the VP of Market Access at Mahana Therapeutics from 2021 to 2022. From 2018 to 2021, they held the position of Vice President, Patient and Market Access at Osmotica Pharmaceutical Corp. In 2015, they were the President of Direct Success, Inc. Before that, they served as the Director of Market Access and Pharmacy at Medimetriks Pharmaceuticals, Inc. from 2013 to 2015. Kelly also worked as the Chief Operating Officer at Advanced Script Specialty Pharmacy from 2010 to 2013 and as an Immunology Sales Specialist at UCB from 2006 to 2010.

Kelly Price attended Baylor University from 1996 to 1998, where they pursued a Bachelor of Science degree in Nursing. Kelly'sfield of study was focused on Registered Nursing/Registered Nurse.